Drug Shortage Report for LOSARTAN HCT
| Report ID | 120588 |
| Drug Identification Number | 02388960 |
| Brand name | LOSARTAN HCT |
| Common or Proper name | LOSARTAN HCT |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE |
| Strength(s) | 50MG 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-06-23 |
| Estimated end date | 2021-01-25 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-07-17 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-07-17 | French | Compare |
| v1 | 2020-07-17 | English | Compare |